The role of prostatic interstitium for expression of the obstructive symptom and prostatic growth of benign prostatic hyperplasia
前列腺间质在良性前列腺增生梗阻症状表现及前列腺生长中的作用
基本信息
- 批准号:05454432
- 负责人:
- 金额:$ 3.39万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The adrenergic stimulation induces the contraction of the hyperplastic tissues via a_l adrenoceptor and pharmacological studies suggested the existence of its subtypes. Recently three subtypes (a_<la>, a_<lb>, a_<ld>) have been detected and cloned using molecular biologic technique. Using the probes for these subtypes, we demonstrated their expression in cases with benign prostatic hypertplasia (BPH) and non-BPH tissues with in situ hybridization method. To quantify the ratio among these subtypes, RNase protection assay was also attempted in these cases. The expression of the a_<la> and a_<ld> adrenoceptors was diffusely reconginzed in the smooth muscles in the interstitium, while not in the glandular epithelial cells. On the contrary, the a_<lb> adrenoceptor was very weakly recognized. In all tissue samples tested, the predominant subtype mRNA was alpha1a. The total abundance of alpha1 mRNA in BPH samples was over six times that in non-BPH samples, the increased expression of alpha1a mRNA accounting for most of this increase (eight times that in non-BPH). The abundance of alpha1b did not vary between BPH and non-BPH samples, and the abundance of a ld in BPH samples was about three times in non-BPH samples. The ratio of the abundance of the subtype mRNAs, alpha1a : alpha1b : alpha1d was 63 : 8 : 29 in non-BPH samples and 85 : 1 : 14 in BPH samples.
肾上腺素刺激通过a_1肾上腺素受体诱导增生组织收缩,药理学研究表明其亚型的存在。最近使用分子生物学技术检测并克隆了三种亚型(a_<la>、a_<lb>、a_<ld>)。使用这些亚型的探针,我们通过原位杂交方法证明了它们在良性前列腺增生(BPH)和非 BPH 组织中的表达。为了量化这些亚型之间的比例,在这些情况下还尝试了 RNase 保护测定。 a_<la>和a_<ld>肾上腺素受体的表达在间质平滑肌中被广泛识别,而在腺上皮细胞中则不然。相反,a_<lb>肾上腺素受体的识别非常弱。在所有测试的组织样本中,主要的 mRNA 亚型是 alpha1a。 BPH 样本中 alpha1 mRNA 的总丰度是非 BPH 样本的六倍多,其中 alpha1a mRNA 表达量的增加占了大部分增加(非 BPH 中的八倍)。 BPH 和非 BPH 样品中 alpha1b 的丰度没有差异,BPH 样品中 ld 的丰度约为非 BPH 样品的三倍。非 BPH 样本中 alpha1a : alpha1b : alpha1d 亚型 mRNA 丰度比为 63 : 8 : 29 ,在 BPH 样本中为 85 : 1 : 14 。
项目成果
期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Moriyama,N.et al.: "Renal aging change of alpha1-adrenoceptor in Wister rat." General Pharmacology. 26. 347-351 (1995)
Moriyama,N.et al.:“Wister 大鼠 α1-肾上腺素受体的肾脏衰老变化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Moriyama, N., Kurimoto, S., Horie, S., Nasu, K., Tanaka, T., Yano, J., Hirano, H., Tsujimoto, G.and Kawabe, K.: "Detection of alpha1-Adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization." Histochem.J.(in press).
Moriyama, N.、Kurimoto, S.、Horie, S.、Nasu, K.、Tanaka, T.、Yano, J.、Hirano, H.、Tsujimoto, G. 和 Kawabe, K.:“检测 alpha1-
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Moriyama,N.,et al.: "Renal aging change of alpha_1-adrenoceptor in Wistar rat." Gen Pharmacol.(in press).
Moriyama,N.,et al.:“Wistar 大鼠 α_1-肾上腺素受体的肾脏老化变化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Moriyama, N., Kurimoto, S., Miata, N., Yamura, H., Yamazaki, R., Sudoh, K., Inagaki, O., Takenaka, T.and Kawabe, K.: "Decreased contractile effect of endothelin-1 on hyperplastic prostate." Gen.Pharmacol.(in press).
Moriyama, N.、Kurimoto, S.、Miata, N.、Yamura, H.、Yamazaki, R.、Sudoh, K.、Inagaki, O.、Takenaka, T. 和 Kawabe, K.:“减少收缩效应
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Moriyama,N.et al.: "Effect of bunazosin,α_1-adrenおoeptor blocker,on multidirectional contractile response and localization of bunazosin binding sites in human hypertrophied prostate." General Pharmacology. 26. 1033-1037 (1995)
Moriyama, N. 等人:“布那佐辛 (α_1-肾上腺素受体阻滞剂) 对人类肥大前列腺中布那佐辛结合位点的多向收缩反应和定位的影响”26. 1033-1037 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORIYAMA Nobuo其他文献
MORIYAMA Nobuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORIYAMA Nobuo', 18)}}的其他基金
The role of Na-HCO_3 cotransporter in metastasis of renal cell carcinoma
Na-HCO_3协同转运蛋白在肾细胞癌转移中的作用
- 批准号:
14571486 - 财政年份:2002
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantification and localization of mRNA levels of endothelin receptor subtypes and preproEndothelin-1 in human urethra
人尿道内皮素受体亚型和前内皮素原-1 mRNA 水平的定量和定位
- 批准号:
12671520 - 财政年份:2000
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Distribution and aging changes of αィイD21ィエD2-adrenoceptor subtype mRNA in human renal artery.
人肾动脉中αD21D2-肾上腺素受体亚型mRNA的分布和老化变化。
- 批准号:
10671459 - 财政年份:1998
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Correlation of clinical data and polymorphism for αィイD21aィエD2-adrenoceptor subtypes gene in Japanese patients with benign prostatic hypertrophy
日本良性前列腺肥大患者临床资料与αD21aD2肾上腺素受体亚型基因多态性的相关性
- 批准号:
09671608 - 财政年份:1997
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
- 批准号:
10607151 - 财政年份:2023
- 资助金额:
$ 3.39万 - 项目类别:
Elucidation of the mechanism of benign prostatic hyperplasia and arteriosclerosis in the general population
阐明普通人群良性前列腺增生和动脉硬化的机制
- 批准号:
22K10571 - 财政年份:2022
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
利用患者报告的结果增强良性前列腺增生治疗的临床决策
- 批准号:
10861513 - 财政年份:2022
- 资助金额:
$ 3.39万 - 项目类别:
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
利用患者报告的结果增强良性前列腺增生治疗的临床决策
- 批准号:
10698073 - 财政年份:2022
- 资助金额:
$ 3.39万 - 项目类别:
Impact of age on altered steroidogenesis and estrogen receptor activation in benign prostatic hyperplasia progression
年龄对良性前列腺增生进展中类固醇生成改变和雌激素受体激活的影响
- 批准号:
9976945 - 财政年份:2020
- 资助金额:
$ 3.39万 - 项目类别:
The role of estrogen receptor in development of benign prostatic hyperplasia
雌激素受体在良性前列腺增生发展中的作用
- 批准号:
20K18094 - 财政年份:2020
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Growth mechanism of benign prostatic hyperplasia by autoimmune reaction using complement factor B knockout rats
利用补体因子 B 敲除大鼠的自身免疫反应研究良性前列腺增生的生长机制
- 批准号:
20K18120 - 财政年份:2020
- 资助金额:
$ 3.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Impact of age on altered steroidogenesis and estrogen receptor activation in benign prostatic hyperplasia progression
年龄对良性前列腺增生进展中类固醇生成改变和雌激素受体激活的影响
- 批准号:
10392989 - 财政年份:2020
- 资助金额:
$ 3.39万 - 项目类别:
Impact of age on altered steroidogenesis and estrogen receptor activation in benign prostatic hyperplasia progression
年龄对良性前列腺增生进展中类固醇生成改变和雌激素受体激活的影响
- 批准号:
10610847 - 财政年份:2020
- 资助金额:
$ 3.39万 - 项目类别:
Impact of age on altered steroidogenesis and estrogen receptor activation in benign prostatic hyperplasia progression
年龄对良性前列腺增生进展中类固醇生成改变和雌激素受体激活的影响
- 批准号:
10161707 - 财政年份:2020
- 资助金额:
$ 3.39万 - 项目类别: